Acute Hip Fracture Study in Patients 65 Years or Greater
Public ClinicalTrials.gov record NCT02578095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Multi-Center Study to Explore the Efficacy, Safety and Tolerability of VK5211 in Subjects With Acute Hip Fracture
Study identification
- NCT ID
- NCT02578095
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Viking Therapeutics, Inc.
- Industry
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- VK5211 Drug
Drug
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2015
- Primary completion
- Nov 14, 2017
- Completion
- Dec 16, 2017
- Last update posted
- Dec 28, 2025
2015 – 2017
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duurga Clinical Service | Yorba Linda | California | 92886 | — |
| Orthopedic Research Institute | Boynton Beach | Florida | 33472 | — |
| Infinite Clinical Research | Doral | Florida | 33126 | — |
| Shrock Orthopedic Research, LLC | Fort Lauderdale | Florida | 33136 | — |
| Center for Advanced Research & Education | Gainesville | Georgia | 30501 | — |
| Orthopaedic Association of Michigan | Grand Rapids | Michigan | 49525 | — |
| University of Wisconsin Osteoporosis Clinical Research Program | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02578095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02578095 live on ClinicalTrials.gov.